Uwe J.F. Tietge, Oliver Selberg, Andreas Kreter, Matthias J. Bahr, Matthias Pirlich, Wolfgang Burchert, Manfred J. Müller, Michael P. Manns, Klaus H.W. Böker – 23 July 2004 – With increasing long‐term survival rates after orthotopic liver transplantation (OLT), metabolic alterations complicating the clinical course, such as diabetes mellitus (DM), become increasingly important. Liver cirrhosis is associated with severe alterations in glucose metabolism. However, it is currently unclear whether these changes are reversed by successful OLT.

Gianni Biancofiore, Giorgio Della Rocca, Lucia Bindi, Anna Romanelli, Massimo Esposito, Luca Meacci, Lucio Urbani, Franco Filipponi, Franco Mosca – 23 July 2004 – With the aim of assessing whether fenoldopam can help to preserve renal function after liver transplantation, we randomized 140 consecutive recipients with comparable preoperative renal function to receive fenoldopam 0.1 μg/kg/minute (group F, 46 patients), dopamine 3 μg/kg/minute (group D, 48 patients), or placebo (group P, 46 patients) from the time of anesthesia induction to 96 hours postoperatively.

Zu‐hua Gao, Vivian C. McAlister, James R. Wright, Chloe C. McAlister, Kevork Peltekian, Allan S. MacDonald – 23 July 2004 – Outcomes may differ after kidney transplantation compared to combined liver‐kidney transplantation. In animal models, distinct patterns of antidonor immunoglobulin (Ig) G subclasses are associated with either rejection or transplant tolerance. Flow cytometry has increased the sensitivity of antidonor immunoglobulin detection. We compared antidonor IgG subclass responses in kidney transplant recipients to those in recipients of liver or multiorgan grafts.

Donald A. Brand, Deborah Viola, Pretam Rampersaud, Patricia A. Patrick, William S. Rosenthal, David C. Wolf – 23 July 2004 – Discussion about the economics of end‐stage liver disease has typically focused on the high cost of liver transplantation, but the management of complications in patients waiting for an organ can also be very expensive. Our research considered the hypothesis that an increase in the number of organ grafts would decrease health care costs in patients with liver disease by eliminating the cost of waiting for an organ.

Gregg A. Miller, Benjamin M. Yeh, Richard S. Breiman, John P. Roberts, Aliya Qayyum, Fergus V. Coakley – 23 July 2004 – Evaluation of the biliary tract after liver transplantation, particularly when a Roux‐en‐Y hepatojejunostomy precludes endoscopic retrograde cholangiography, may be challenging. We present five cases of suspected biliary obstruction after liver transplantation in which multidetector‐row computed tomography (CT) cholangiography was used.

Rajesh N. Keswani, Aijaz Ahmed, Emmet B. Keeffe – 23 July 2004 – Patients older than 60 are undergoing transplantation with increasing frequency. Reports from several transplant centers document that overall short‐term patient survival rates in seniors undergoing liver transplantation are comparable to survival rates of younger adults. However, specific subgroups of older patients may not fare as well. Seniors with far‐advanced end‐stage liver disease are high‐risk for liver transplantation and have poor survival rates.

Nelson Leung, Stephen C. Textor – 23 July 2004

Bjørn Brandsaeter, Erik Schrumpf, Ole Petter Clausen, Andreas Abildgaard, Geir Hafsahl, Kristian Bjøro – 23 July 2004

Richard Freeman – 23 July 2004

Zakiyah Kadry, Nazia Selzner, Markus Selzner, Pierre‐Alain Clavien – 23 July 2004